Skip to content
soligenix-logo Soligenix Logo
Main Menu
  • About Soligenix
    • Corporate Overview
    • Board of Directors
    • Executive Team
    • Scientific Advisory Boards
      • Scientific Advisory Board Cutaneous T-Cell Lymphoma
      • European Medical Advisory Board for Cutaneous T-Cell Lymphoma
      • Scientific Advisory Board Oral Mucositis
      • Scientific Advisory Board Pediatric Crohn’s Disease
      • Behçet’s Disease Medical Advisory Board
      • Scientific Advisory Board Antibiotic Resistance & Emerging Infectious Disease
      • Scientific Advisory Board Psoriasis
  • Careers
    • Job Openings
  • Contact
  • Pipeline + Programs
    • Pipeline
    • Specialized BioTherapeutics
      • HyBryte™ Cutaneous T-Cell Lymphoma (CTCL) Treatment
      • SGX302 Plaque Psoriasis Treatment for Mild to Moderate Psoriasis
      • SGX942 for Oral Mucositis Treatment
      • SGX945 for Aphthous Ulcers of Behçet’s Disease
      • SGX203 for Pediatric Crohn’s Disease
    • Public Health Solutions
      • RiVax® to Prevent Ricin Poisoning
      • SGX943 for Bacterial Infection Treatment
      • ThermoVax® Thermostable Vaccines for Global Use
    • Reference Literature
      • Specialized BioTherapeutics
      • Public Health Solutions
    • Relevant Publications
  • Clinical Trials
  • Our Focus
    • Specialized BioTherapeutics
      • Cutaneous T-Cell Lymphoma
      • Psoriasis
      • Oral Mucositis
      • Behçet’s Disease
      • Pediatric Crohn’s Disease
    • Public Health Solutions
      • What is Ricin Intoxication?
      • Thermal Stabilization of Vaccines
      • Antibiotic Resistant & Emerging Infectious Disease
  • Partnering
  • Investors
T-cell masthead image

Legal Notices

  • FCOI Disclosures
  • Legal Notice
  • Privacy Policy
  • Policy On Financial Conflicts Of Interest In U.S. Public Health Service Funded Research

© Soligenix, 2025. All Rights Reserved.
  • Legal Notices
  • Site Map
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
  • Instagram